RTW INVESTMENTS, LP — SEC insider filings
SEC reporting owner CIK 1493215. 49 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 49 filings on record, filed 2020-08-19 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 42 legs across 22 filings — 9,745,233 shares, $134,531,643 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 3,132,378 shares, $56,462,766 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 80.
- Largest priced transaction: sale of 725,000 shares @ $40.03 ($29,023,490) in ROCKET PHARMACEUTICALS, INC., filed 2021-05-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | Director, 10% owner | 12 | 2 legs · 1,603,652 sh · $33,872,317 | 1 leg · 725,000 sh · $29,023,490 | 25 |
| Milestone Pharmaceuticals Inc. (MIST) | 10% owner | 4 | 1 leg · 1,557,346 sh · $13,564,484 | 1 leg · 1,557,346 sh · $13,564,484 | 3 |
| Prometheus Biosciences, Inc. (RXDX) | 10% owner | 1 | 1 leg · 800,000 sh · $15,200,000 | — | 4 |
| Renovacor, Inc. (RCOR) | 10% owner | 11 | 30 legs · 1,609,335 sh · $14,569,141 | — | 2 |
| Avidity Biosciences, Inc. (RNA) | 10% owner | 1 | 1 leg · 800,000 sh · $14,400,000 | — | 1 |
| Tarsus Pharmaceuticals, Inc. (TARS) | 10% owner | 1 | — | 1 leg · 450,000 sh · $13,491,000 | — |
| Athira Pharma, Inc. (ATHA) | 10% owner | 1 | 1 leg · 750,000 sh · $12,750,000 | — | 2 |
| Landos Biopharma, Inc. (LABP) | 10% owner | 2 | 1 leg · 625,000 sh · $10,000,000 | 1 leg · 300,000 sh · $207,000 | 2 |
| Kailera Therapeutics, Inc. (KLRA) | 10% owner | 1 | 1 leg · 500,000 sh · $8,000,000 | — | 3 |
| Orchestra BioMed Holdings, Inc. (OBIO) | 10% owner | 7 | 3 legs · 1,299,900 sh · $6,275,701 | 1 leg · 32 sh · $132 | 5 |
+3 more issuers among the filings shown — every filing appears in the table below.
Insider filings — RTW INVESTMENTS, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Purchase (P): 1,200,000 @ $5 | EDGAR |
| 2026-07-23 | 4 | ALLURION TECHNOLOGIES, INC. (ALUR) jointly with WONG RODERICK | Other (J): 209,254 · Other (J): 161,807 · Other (J): 19,934 · Other (J): 1,771 · Other (J): 209,254 (derivative) · Other (J): 161,807 (derivative) · +2 more | EDGAR |
| 2026-04-29 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Option exercise/expiry (X): 1,250,032 @ $0.00 · Sale (S): 32 @ $4.13 · Option exercise/expiry (X): 1,250,032 (derivative) @ $2.75 | EDGAR |
| 2026-04-22 | 4 | Kailera Therapeutics, Inc. (KLRA) jointly with WONG RODERICK | Conversion (C): 10,276,820 · Purchase (P): 500,000 @ $16 · Conversion (C): 8,250,000 (derivative) · Conversion (C): 2,026,820 (derivative) | EDGAR |
| 2025-11-13 | 4 | ALLURION TECHNOLOGIES, INC. (ALUR) jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd. | Grant/award (A): 991,544 @ $1.67 · Grant/award (A): 767,848 @ $1.67 · Grant/award (A): 96,896 @ $1.67 · Grant/award (A): 991,544 (derivative) · Grant/award (A): 767,848 (derivative) · Grant/award (A): 96,896 (derivative) | EDGAR |
| 2025-11-07 | 4 | ALLURION TECHNOLOGIES, INC. (ALUR) jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd. | Conversion (C): 822,722 @ $3.35 · Conversion (C): 631,954 @ $3.35 · Conversion (C): 37,863 @ $3.35 · Grant/award (A) @ $2,756,117 · Conversion (C) @ $2,756,117 · Grant/award (A) @ $2,117,044 · +3 more | EDGAR |
| 2025-09-23 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Option exercise/expiry (X): 1,000,000 @ $40.03 · Other (J): 1,000,000 @ $3.10 · Option exercise/expiry (X): 41,000 @ $19.09 · Other (J): 41,000 @ $3.10 · Option exercise/expiry (X): 59,000 @ $17.81 · Other (J): 59,000 @ $3.10 · +3 more | EDGAR |
| 2025-08-06 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Purchase (P): 3,636,363 (derivative) @ $2.75 | EDGAR |
| 2025-05-01 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Purchase (P): 49,900 @ $2.99 | EDGAR |
| 2025-04-29 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Purchase (P): 50,000 @ $2.53 | EDGAR |
| 2025-04-17 | 4 | ALLURION TECHNOLOGIES, INC. (ALUR) jointly with WONG RODERICK, RTW MASTER FUND, LTD., RTW Innovation Master Fund Ltd. | Conversion (C): 822,722 @ $3.35 · Conversion (C): 631,954 @ $3.35 · Conversion (C): 37,863 @ $3.35 · Grant/award (A) @ $5,000,000 · Conversion (C) @ $5,000,000 | EDGAR |
| 2024-12-16 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Grant/award (A): 400,000 (derivative) @ $12.49 | EDGAR |
| 2024-01-16 | 4 | CARGO Therapeutics, Inc. (CRGX) jointly with WONG RODERICK | Other (J): 1,842,499 | EDGAR |
| 2023-09-19 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Purchase (P): 3,126,955 (derivative) @ $15.99 | EDGAR |
| 2023-08-30 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Other (J): 500,000 @ $22.05 · Other (J): 500,000 @ $15.87 · Other (J): 500,000 @ $22.05 · Other (J): 500,000 @ $15.87 · Other (J): 1 (derivative) · Other (J): 1 (derivative) | EDGAR |
| 2023-05-05 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Other (J): 502,133 | EDGAR |
| 2023-04-05 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Other (J): 529,038 · Other (J): 1 (derivative) · Other (J): 61,705 (derivative) | EDGAR |
| 2023-04-05 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK | Other (J): 3,000,803 · Other (J): 350,000 (derivative) | EDGAR |
| 2023-03-24 | 4 | Milestone Pharmaceuticals Inc. (MIST) jointly with WONG RODERICK | Other (J): 1,059,000 | EDGAR |
| 2023-01-30 | 4 | Orchestra BioMed Holdings, Inc. (OBIO) jointly with WONG RODERICK | Grant/award (A): 2,310,000 | EDGAR |
| 2022-12-23 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Other (J): 1 (derivative) | EDGAR |
| 2022-12-22 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Other (J): 1 (derivative) | EDGAR |
| 2022-11-08 | 4 | DermTech, Inc. (DMTK) jointly with WONG RODERICK | Option exercise/expiry (X): 31,450 @ $9.54 · Sale (S): 100,000 @ $1.77 · Option exercise/expiry (X): 31,450 (derivative) @ $9.54 | EDGAR |
| 2022-10-11 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK | Purchase (P): 1,355,932 @ $14.75 | EDGAR |
| 2022-09-27 | 4 | Landos Biopharma, Inc. (LABP) jointly with WONG RODERICK | Sale (S): 300,000 @ $0.69 | EDGAR |
| 2022-09-09 | 4 | Milestone Pharmaceuticals Inc. (MIST) jointly with WONG RODERICK | Purchase (P): 1,557,346 @ $8.71 · Sale (S): 1,557,346 @ $8.71 | EDGAR |
| 2022-01-20 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK | Purchase (P): 44,440 @ $8 | EDGAR |
| 2022-01-14 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK | Purchase (P): 1,950 @ $7.67 · Purchase (P): 286 @ $7.75 · Purchase (P): 145,000 @ $8.00 · Purchase (P): 5,723 @ $8 | EDGAR |
| 2022-01-06 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 3.93 @ $8 · Purchase (P): 100,195 @ $8.00 · Purchase (P): 51,296 @ $8 | EDGAR |
| 2022-01-03 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 479 @ $8 · Purchase (P): 3,743 @ $8 · Purchase (P): 441 @ $7.95 | EDGAR |
| 2021-12-28 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 61,584 @ $7.97 · Purchase (P): 4,905 @ $7.99 | EDGAR |
| 2021-12-22 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 129,516 @ $7.96 · Purchase (P): 800 @ $7.73 · Purchase (P): 3,609 @ $8.00 · Purchase (P): 1,864 @ $7.99 · Purchase (P): 3,500 @ $7.95 | EDGAR |
| 2021-11-17 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 600 @ $9.05 · Purchase (P): 3,720 @ $9.00 · Purchase (P): 42,410 @ $9 · Purchase (P): 21,161 @ $9.00 | EDGAR |
| 2021-11-12 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 8,949 @ $8.25 · Purchase (P): 319 @ $8.44 · Purchase (P): 631 @ $8.50 | EDGAR |
| 2021-11-08 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK, RTW MASTER FUND, LTD. | Purchase (P): 57,914 @ $8.03 · Purchase (P): 13,157 @ $8.38 · Purchase (P): 1,130 @ $8.34 · Purchase (P): 100,009 @ $8.25 | EDGAR |
| 2021-09-07 | 4 | Renovacor, Inc. (RCOR) jointly with WONG RODERICK | Purchase (P): 800,000 @ $10 | EDGAR |
| 2021-08-31 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK, Yalamanchi Naveen | Grant/award (A): 812,516 @ $32.48 | EDGAR |
| 2021-08-06 | 4 | Avidity Biosciences, Inc. (RNA) jointly with WONG RODERICK | Purchase (P): 800,000 @ $18 · Conversion (C): 3,995,000 (derivative) | EDGAR |
| 2021-05-24 | 4 | Milestone Pharmaceuticals Inc. (MIST) jointly with WONG RODERICK | Purchase (P): 910,746 (derivative) @ $5.48 | EDGAR |
| 2021-05-13 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK, Yalamanchi Naveen | Sale (S): 725,000 @ $40.03 · Other (J): 1 (derivative) | EDGAR |
| 2021-05-07 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) jointly with WONG RODERICK | Sale (S): 450,000 @ $29.98 | EDGAR |
| 2021-03-29 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK, Yalamanchi Naveen | Other (J): 1,344,925 | EDGAR |
| 2021-03-16 | 4 | Prometheus Biosciences, Inc. (RXDX) jointly with WONG RODERICK | Purchase (P): 800,000 @ $19 · Conversion (C): 1,017,769 · Conversion (C): 1,446,262 · Conversion (C): 10,177,703 (derivative) · Conversion (C): 14,462,623 (derivative) | EDGAR |
| 2021-02-08 | 4 | Landos Biopharma, Inc. (LABP) jointly with WONG RODERICK | Purchase (P): 625,000 @ $16 · Conversion (C): 3,650,722 · Conversion (C): 3,650,722 (derivative) | EDGAR |
| 2021-01-11 | 4 | DermTech, Inc. (DMTK) jointly with WONG RODERICK | Purchase (P): 200,000 @ $29.50 | EDGAR |
| 2020-12-14 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) jointly with WONG RODERICK, Yalamanchi Naveen | Purchase (P): 247,720 @ $56 | EDGAR |
| 2020-10-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) jointly with WONG RODERICK | Purchase (P): 952,380 (derivative) @ $5.24 | EDGAR |
| 2020-09-22 | 4 | Athira Pharma, Inc. (ATHA) jointly with WONG RODERICK | Conversion (C): 1,535,131 · Purchase (P): 750,000 @ $17 · Conversion (C): 1,535,131 (derivative) | EDGAR |
| 2020-08-19 | 4 | DermTech, Inc. (DMTK) jointly with WONG RODERICK | Option exercise/expiry (X): 31,450 @ $9.54 · Option exercise/expiry (X): 31,450 (derivative) @ $9.54 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1493215 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs